Numerous studies report chronic inflammation as an important factor in these diseases and conditions:
Hyperbaric oxygen therapy (HBOT) has been demonstrated to substantially attenuate inflammation throughout the body. HBOT drives increased levels of oxygen into the body, which travels through the plasma, subsequently reducing inflammation and pain. Studies have shown that HBOT increases anti-inflammatory levels and provides increased cellular aid to heal target regions. As oxygen serves as one of the primary mechanisms to ameliorating inflammation, HBOT creates the environment where this process is stimulated and enhanced.
Studies have shown that hyperbaric oxygen therapy is an effective treatment for reducing inflammation in the following ways:
Inflammation is a factor that is common to many age-related conditions and diseases. Additionally, those who are interested in longevity (life extension) and bio-hacking are also interested in therapies that reduce inflammation.
A study published in 2007 examined the effects of HBOT for atherosclerosis (plaques of fatty material that line the walls of arteries) with mice. Two groups of mice were treated with either 5 or 10 weeks of HBOT, whereas two other groups remained untreated and were used as a control group. After the introduction of low-density lipoprotein, the treated group exhibited positive changes in the immune/inflammatory response. This represents a critical component of the beneficial effects of HBOT. This study demonstrated that HBOT significantly reduced the circulating levels of low-density lipoprotein that can cause heart disease, kidney disease, and stroke. Additionally, HBOT resulted in a substantial attenuation in the production of pro-inflammatory cytokines in response to an inflammatory stimulus and showed a marked increase in the production of anti-inflammatory cytokine Interleukin 10 by spleen cells. The observed improvements were already noted after only 5 weeks of treatment.
The following research highlights the benefit of hyperbaric oxygen therapy and inflammation reduction.